Atheroprotective Effects and Molecular Mechanism of Berberine

Atheroprotective Effects and Molecular Mechanism of Berberine

Cardiovascular diseases remain the leading cause of morbidity and mortality worldwide. Atherosclerosis is the main pathological basis of cardiovascular diseases and it is closely associated with hyperlipidemia, endothelial injury, macrophage-derived foam cells formation, proliferation and migration...

Full description

Bibliographic Details
Main Authors:	Lu Xing, Xin Zhou, Ai-Hong Li, Hui-Jin Li, Chun-Xia He, Wei Qin, Dong Zhao, Peng-Quan Li, Li Zhu, Hui-Ling Cao
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-11-01
Series:	Frontiers in Molecular Biosciences
Subjects:	atherosclerosis berberine molecular mechanism cell targets gut microbiota
Online Access:	https://www.frontiersin.org/articles/10.3389/fmolb.2021.762673/full

Similar Items

Multi-Pharmacology of Berberine in Atherosclerosis and Metabolic Diseases: Potential Contribution of Gut Microbiota
by: Shengjie Yang, et al.
Published: (2021-07-01)

The Effective Role of Natural Product Berberine in Modulating Oxidative Stress and Inflammation Related Atherosclerosis: Novel Insights Into the Gut-Heart Axis Evidenced by Genetic Sequencing Analysis
by: Richard Y. Cao, et al.
Published: (2021-12-01)

Effectiveness and safety of Bifidobacterium and berberine in human hyperglycemia and their regulatory effect on the gut microbiota: a multi-center, double-blind, randomized, parallel-controlled study
by: Jie Ming, et al.
Published: (2021-08-01)

Modulation of Microbiota-Gut-Brain Axis by Berberine Resulting in Improved Metabolic Status in High-Fat Diet-Fed Rats
by: Honglin Sun, et al.
Published: (2016-11-01)

Dietary supplementation with berberine improves growth performance and modulates the composition and function of cecal microbiota in yellow-feathered broilers
by: Cui Zhu, et al.
Published: (2021-02-01)

Diversity of the Gut Microbiota in Dihydrotestosterone-Induced PCOS Rats and the Pharmacologic Effects of Diane-35, Probiotics, and Berberine
by: Feifei Zhang, et al.
Published: (2019-02-01)

Berberrubine, a Main Metabolite of Berberine, Alleviates Non-Alcoholic Fatty Liver Disease via Modulating Glucose and Lipid Metabolism and Restoring Gut Microbiota
by: Sa Yang, et al.
Published: (2022-07-01)

The mechanism of berberine alleviating metabolic disorder based on gut microbiome
by: Han Wang, et al.
Published: (2022-08-01)

Transformation of berberine to its demethylated metabolites by the CYP51 enzyme in the gut microbiota
by: Zheng-Wei Zhang, et al.
Published: (2021-10-01)

Berberine inhibits intestinal carcinogenesis by suppressing intestinal pro-inflammatory genes and oncogenic factors through modulating gut microbiota
by: Haitao Chen, et al.
Published: (2022-05-01)

Berberine is a potential alternative for metformin with good regulatory effect on lipids in treating metabolic diseases
by: Hui-Hui Guo, et al.
Published: (2023-07-01)

Suppression of Berberine and Probiotics (in vitro and in vivo) on the Growth of Colon Cancer With Modulation of Gut Microbiota and Butyrate Production
by: Chao Huang, et al.
Published: (2022-04-01)

Dietary Berberine and Ellagic Acid Supplementation Improve Growth Performance and Intestinal Damage by Regulating the Structural Function of Gut Microbiota and SCFAs in Weaned Piglets
by: Wenxia Qin, et al.
Published: (2023-05-01)

Stachyose Improves the Effects of Berberine on Glucose Metabolism by Regulating Intestinal Microbiota and Short-Chain Fatty Acids in Spontaneous Type 2 Diabetic KKAy Mice
by: Hui Cao, et al.
Published: (2020-10-01)

Berberine as a Potential Agent for the Treatment of Colorectal Cancer
by: Xi Jiang, et al.
Published: (2022-04-01)

Disulfiram Reduces Atherosclerosis and Enhances Efferocytosis, Autophagy, and Atheroprotective Gut Microbiota in Hyperlipidemic Mice
by: C. Alicia Traughber, et al.
Published: (2024-04-01)

Effect and Mechanism of Pharmaceutical Excipients on Berberine to Alleviate Ulcerative Colitis via Regulating Gut Microbiota
by: Chenyang Wu, et al.
Published: (2022-09-01)

Berberine-microbiota interplay: orchestrating gut health through modulation of the gut microbiota and metabolic transformation into bioactive metabolites
by: Tessa Dehau, et al.
Published: (2023-12-01)

The Effects of Berberine on the Gut Microbiota in Apc min/+ Mice Fed with a High Fat Diet
by: Huan Wang, et al.
Published: (2018-09-01)

Berberine improved the microbiota in lung tissue of colon cancer and reversed the bronchial epithelial cell changes caused by cancer cells
by: Wei Yang, et al.
Published: (2024-01-01)

Modulation of Gut Microbiota and Metabolites by Berberine in Treating Mice With Disturbances in Glucose and Lipid Metabolism
by: Xinyi Fang, et al.
Published: (2022-06-01)

Berberine Promotes Induction of Immunological Tolerance to an Allograft via Downregulating Memory CD8+ T-Cells Through Altering the Gut Microbiota
by: Feifei Qiu, et al.
Published: (2021-02-01)

Study on the protective effect of berberine treatment on sepsis based on gut microbiota and metabolomic analysis
by: Huibin Pan, et al.
Published: (2022-12-01)

Functional nano-vector boost anti-atherosclerosis efficacy of berberine in Apoe(−/−) mice
by: Xiaolei Ma, et al.
Published: (2020-09-01)

Rhubarb polysaccharide and berberine co-assembled nanoparticles ameliorate ulcerative colitis by regulating the intestinal flora
by: Yifan Feng, et al.
Published: (2023-06-01)

Dissecting the Effect of Berberine on the Intestinal Microbiome in the Weaned Piglets by Metagenomic Sequencing
by: Hong Hu, et al.
Published: (2022-04-01)

Berberine Relieves Metabolic Syndrome in Mice by Inhibiting Liver Inflammation Caused by a High-Fat Diet and Potential Association With Gut Microbiota
by: Jinjin Li, et al.
Published: (2022-01-01)

Berberine ameliorates chronic kidney disease through inhibiting the production of gut-derived uremic toxins in the gut microbiota
by: Libin Pan, et al.
Published: (2023-04-01)

Berberine Alleviates Non-alcoholic Steatohepatitis Through Modulating Gut Microbiota Mediated Intestinal FXR Activation
by: Xiangbing Shu, et al.
Published: (2021-09-01)

Berberine Regulates Treg/Th17 Balance to Treat Ulcerative Colitis Through Modulating the Gut Microbiota in the Colon
by: Huantian Cui, et al.
Published: (2018-05-01)

Berberine regulates glucose metabolism in largemouth bass by modulating intestinal microbiota
by: Yun Xia, et al.
Published: (2023-03-01)

A High Dose of Dietary Berberine Improves Gut Wall Morphology, Despite an Expansion of Enterobacteriaceae and a Reduction in Beneficial Microbiota in Broiler Chickens
by: Tessa Dehau, et al.
Published: (2023-02-01)

Berberine improves DSS-induced colitis in mice by modulating the fecal-bacteria-related bile acid metabolism
by: Xiongjie Sun, et al.
Published: (2023-11-01)

A Holistic View of Berberine Inhibiting Intestinal Carcinogenesis in Conventional Mice Based on Microbiome-Metabolomics Analysis
by: Haitao Chen, et al.
Published: (2020-09-01)

Berberine influences multiple diseases by modifying gut microbiota
by: Fujie Yang, et al.
Published: (2023-08-01)

Neuroprotective Properties of Berberine: Molecular Mechanisms and Clinical Implications
by: Erjie Tian, et al.
Published: (2023-10-01)

Promising Antioxidative Effect of Berberine in Cardiovascular Diseases
by: Na An, et al.
Published: (2022-03-01)

Molecular and Crystal Structures of Three Berberine Derivatives
by: JiÃ…Â™ÃƒÂ DostÃƒÂ¡l, et al.
Published: (2001-04-01)

Evaluation of berberine inhibitory effects on influenza neuraminidase enzyme: A molecular dynamics study
by: Majid Asadi-Samani, et al.
Published: (2023-09-01)

Effects of Berberine on Atherosclerosis
by: Rui Rui, et al.
Published: (2021-11-01)